NMDAr autoimmune encephalitis by Excellentrank published on 2022-12-09T16:42:07Z This is the first-ever Clinical Trial for a promising new drug, Inebilizumab, to treat anti-NMDA receptor encephalitis, and will be funded by the National Institutes of Health (NIH). For more information on autoimmune encephalitis treatment, please visit www.autoimmune-encephalitis.org or call 352-527-2470 Genre health